Show Summary Details
Page of

Pharmacological and other biological treatments of suicidal individuals 

Pharmacological and other biological treatments of suicidal individuals
Chapter:
Pharmacological and other biological treatments of suicidal individuals
Author(s):

Hans-Jurgen Möller

DOI:
10.1093/med/9780198570059.003.0054
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 August 2019

Due to the role of depressive disorders, as the most frequent cause of suicidal behaviour, antidepressants have the most prominent place in psychopharmacological prevention of suicidal behaviour. Based on clinical experience, antidepressants reduce suicidality in association with the reduction of depressive symptoms, and it is assumed that suicidal behaviour is also reduced as a consequence. However, based on the results of empirical studies, the evidence is not as clear as clinicians like to believe, which might, in part, be due to methodological problems. Other pharmacological and biological treatment methods with lithium, neuroleptics, benzodiazepines, anti-epileptics and ECT are described as well.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.